(NYSE: SOLV) Solventum's forecast annual revenue growth rate of 2.29% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Solventum's revenue in 2025 is $8,308,000,000.On average, 4 Wall Street analysts forecast SOLV's revenue for 2025 to be $1,458,278,860,023, with the lowest SOLV revenue forecast at $1,455,903,738,630, and the highest SOLV revenue forecast at $1,464,799,198,015. On average, 4 Wall Street analysts forecast SOLV's revenue for 2026 to be $1,494,788,219,837, with the lowest SOLV revenue forecast at $1,474,589,134,206, and the highest SOLV revenue forecast at $1,519,554,846,608.
In 2027, SOLV is forecast to generate $1,540,162,069,722 in revenue, with the lowest revenue forecast at $1,508,672,679,840 and the highest revenue forecast at $1,576,324,019,588.